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PERCUTANEOUS ABSORPTION. ON THE RELEVANCE OF IN VITRO DATA 
THOMAS J. FRANZ, M.D. 
Toilet Goods Division, The Procter & Gamble Company, Cincinnati, Ohio 
The use of in vitro preparations of human skin to study percutaneous absorption is 
widespread. Yet, up to the present time, little has been done to systematically validate this 
model and demonstrate the extent to which it mimicks in vivo absorption. 
In this study, the permeability of 12 organic compounds has been evaluated in excised skin 
and the results compared to those obtained previously by others in living man. With special 
emphasis being given here to duplicating in vivo conditions, it was possible to demonstrate an 
excellent qualitative agreement between the two methods. In all cases, the absorption pattern 
determined in vitro rather precisely paralleled the pattern which was obtained in vivo. 
Quantitative agreement between the two sets of data was less than perfect, although the in 
vitro method adequately distinguished compounds of low permeability from those of high 
permeability and ranked them in approximately the same order found in vivo. This 
systematic comparison of in vitro with in vivo data has clearly shown how accurately in vitro 
absorption studies can reflect the living state. 
Much of the definitive work being done today in 
the area of percutaneous absorption makes use of 
excised human skin as a model for its living 
counterpart. Recent publications by Scheuplein et 
a! [1], Ostrenga et a! [2,3] and Newbold and 
Stoughton [4] demonstrate application of the in 
vitro technique to important problems in dermato-
pharmacology. The definition of fundamental 
physical-chemical parameters underlying absorp-
tion, enhancement of topical therapy through the 
development of new and improved vehicles, new 
drug development and percutaneous pharmacol-
ogy in general, can all be approached through the 
use of in vitro techniques. The future may well see 
increased use made of this technique in the field of 
percutaneous toxicology. Certainly the recent re-
newal of our appreciation of the importance of 
systemic effects of topically applied materials, i.e., 
hexachlorophene [5], has helped to focus attention 
on this area. 
A review of the current understanding of percu-
taneous absorption will clearly reveal the large 
extent to which we rely on in vitro data [6]. 
Unfortunately, little has been done to correlate 
data obtained from excised skin with that obtained 
in vivo, and it leaves unanswered th~ question as to 
how far one may validly extrapolate in vitro 
results. Are they a true and accurate reflection, 
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both qualitatively and quantitatively, of percu-
taneous absorption as it occurs in living man? The 
present work has been designed to explore this 
important question. Using excised human skin, the 
percutaneous absorption of 12 organic compounds 
has been determined and the results compared to 
those obtained in vivo by Feldmann and Maibach 
[7]. The data generated afford an opportunity for a 
more critical evaluation of the relevance of in vitro 
experimentation to the study of percutaneous ab-
sorption in living man. 
MATERIALS AND METHODS 
General Considerations 
An essential part of the work to be described here is 
accurate simulation of the technique used in vivo by 
Feldmann and Maibach [7]. In their work, a small 
amount of a "C-Iabeled material was dissolved in ace-
tone and applied to 13 em' of the ventral forearm of 
human volunteers, the dose being 4 l'g/cm'. Over the 
next 5 days total urinary output was collected serially 
and analyzed for its content of radioactivity. From these 
data it was possible to calculate both the rate of 
absorption and the total absorption of the particular 
compound. 
Insofar as the kidney represents only one possible route 
of exit from the body, it was necessary to correct, in the in 
vivo study, for material which was absorbed but excreted 
via extrarenal pathways. This was accomplished through 
the use of an intravenous dose of the same compound, 
which allows one to determine that fraction of a known 
"absorbed" dose excreted into the urine. The assumption 
is made that a similar fractional excretion will obtain 
following topical application and absorption, and losses 
via extrarenal pathways can then be estimated. Obvi-
ously, this last consideration disappears when one does 
in vitro work. 
A problem with some of the methods employed in the 
study of in vitro percutaneous absorption is that little 
attention has been given to duplicating conditions which 
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confront the skin in vivo. This has in no way jecpardized 
the validity of the work, but simply reflects objectives 
different from those of the present paper. Of major 
concern here has been the use of fully hydrated skin, skin 
which faces an aqueous environment on both its dermal 
and epidermal sides, for example, see Blank [8j, Mali et 
al [9], Scheuplein [10], and Treheme [11]. This situation 
seldom obtains in living man, and is generally known to 
significantly alter the permeability characteristics of the 
stratum corneum. A recent paper by Scheuplein and Ross 
[12] emphasizes this same point, and they clearly demon· 
strate some of the differences between a fully hydrated 
and partially hydrated skin. 
In the work to he reported here, an attempt has been 
made, where possible, to insure that the conditions are 
relevant to living man and closely follow those used in 
vivo [7j. 
Skin Preparation and Mounting 
As it proved impossible to obtain large amounts of 
forearm skin, the site used in the in vivo study, all of the 
in vitro experiments utilized unselected human abdomi· 
nal skin obtained at autopsy. Immediately following 
excision it was placed in plastic bags and stored in a 
freezer, for periods up to but not exceeding 3 months. 
(This method of storage did not appear to damage the 
barrier since no difference in permeability was observed 
between fresh and frozen segments of the same skin as 
determined in a separate series of experiments.) Before 
use, the skin was allowed to thaw gradually to room 
temperature, following which all subcutaneous fat was 
removed by scalpel. From each specimen (the skin of a 
single donor), multiple pieces were cut, generally 6 to 10. 
In this way the absorption of each compound under 
investigation was determined in duplicate or triplicate, 
and several compounds were simultaneously evaluated 
on any one specimen. 
Each piece of skin was mounted in a special glass 
chamber shown schematically in Figure 1. The basic 
component of the chamber is an 0-ring ball joint. Two 
different sizes were rountindy used, one having a nomi-
nal available diffusion area of 1 em', and the other 2.5 
em'. The skin was held between two ball joints, on an 
0-ring, using a pinchtype, ground joint clamp. The 







FIG. 1. Schematic representation of the diffusion cell 
used in these studies. Top is open to the ambient 
laboratory environment. 
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laboratory conditions, while the dermal side was bathed 
by a solution containing 140 mM sodium chloride, 0.1 mM 
sodium pyrithione (antibacterial/antifungal), 0.4 mM 
KH.PO., and 2.0 mM K,HPO,, pH 7.4. Stirring of the 
solution was accomplished by a magnet which was 
mounted on a 600-rpm timing motor located below the 
chamber. This impelled a small Teflon-covered magnet 
located in the bottom, expanded portion of tbe chamber. 
The temperature of this solution was maintained at 
37°C ( ± 0.5°C) by circulating water at the appropriate 
temperature through a jacket which surrounded the 
chamber. 
Experimental Procedure 
Following mounting, each piece of skin was allowed to 
stand for several hours before beginning an experiment. 
This allowed some time for equilibration with respect to 
the temperature and relative humidity of the surrounding 
environment. At time zero a small amount of the 
compound in question, radioactively labeled and dis-
solved in acetone, was added to the epidermal surface 
using a micropipette. The volume added was 10 I'Vcm', 
which is sufficient to spread across tbe entire exposed 
surface, yet readily evaporate in less than a minute. In 
the in vivo study [7] the dose of the tracer compound was 
specified to be 4 ,.gfcm'. Due to the low specific activity 
of some compounds and the limited area of skin availa-
ble, that was not always possible in this study. The dose 
ranged from 4 to 40 ,.gfcm'. The difference is of no 
consequence since, in that range, the flux should be 
directly proportional to the applied dose. With two 
compounds, thiourea and salicylic acid, this assumption 
was tested. Doses of 4 and 40 l'g/cm' were applied to 
separate pieces of skin from the same donor. No differ-
ences in the percent of applied dose absorbed were 
observed. 
At selected intervals, following the addition of tracer to 
the epidermis, the dermal bathing solution was removed 
in its entirety, gelled (lnsta-Gel, Packard Instrument 
Co., Downers Grove, Ill.), and analyzed for its content of 
radioactivity in a liquid scintillation spectrometer. From 
this, the amount which had penetrated was calculated. 
The total amount absorbed divided by the dose applied 
gives the percent absorption. 
Two different types of experiments were performed 
with each compound. ln the majority of cases, just tbe 
total amount absorbed was determined. This required 
that only one sample be taken at 24-hr intervals. In other 
experiments, the kinetics of the absorption process (i.e., 
flux as a function of time) were determined. For this, 
frequent samples were taken throughout the day. Gener-
ally, 1- to 2-hr intervals were employed over the first 24 
hr, and 3- to 6-hr intervals. over the remaining few days. 
Of the 21 organic compounds studied in vivo [7], 12 
have been examined in this study. They are acetylsali-
cylic acid, benzoic acid. caffeine, chloramphenicol, dini· 
trochlorobenzene, hippuric acid. nicotinamide, nicotinic 
acid, phenol, salicylic acid, thiourea, and urea. The 12 
were selected on a random basis, although highly water-
insoluble compounds like hexachlorophene were ex· 
eluded, since it was felt that their in vitro permeability 
might be artificially limited due to insolubility in the 
dermal bathing solution. All of the radioactive com-
pounds were obtained from New England Nuclear Corpo-
ration (Boston, Mass.) with the exception of dinitro-
chlorobenzene which was obtained from Amersham-
Searle (Arlington Heights, Ill.), and all had specific 
activities greater than 2 mCi/mmole. 
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RESULTS 
Rate of Absorption 
As a first test of the validity of the in vitro 
method used here, a comparison of the rates of 
absorption determined in this work with those 
previously determined in vivo [7] were made. This 
is shown in Figures 2-4. The in vivo data represent 
averaged data taken directly from Table Ill of 
Feldmann and Maibach [7], whereas the in vitro 
data are taken from a single representative experi-
ment. 
The absence of a steady state in the rate of 
absorption curves presented in the Figures requires 
some explanation. It must be remembered that 
very small amounts of the compounds being stud-
ied were applied to the surface of the skin. This is 
in keeping with the technique employed in vivo 
and is in marked contrast to the type of in vitro 
experiment most commonly found in the literature 
[8-11 ]. Usually, in vitro experiments have the skin 
exposed to an infinite source of the compound in 
question which ultimately leads to the establish-
ment of a constant rate of absorption, a steady 
state. The absence of an infinite source in the 
experiments reported here underlies the absence of 
a steady state. 
In Figures 2A and B, the rates of absorption of 
benzoic acid and dinitrochlorobenzene are pre-
sented. The absorption patterns of both com-
pounds are quite similar, with a rapid buildup 
·-
FIG. 2. Comparison of the rate of absorption as deter-
mined in vitro and in vivo for (A) benzoic acid and (B) 
dinitrochlorobenzene. 
FIG. 3. Comparison of the rate of absorption as deter-
mined in vitro and in vivo for (A) caffeine and (B) 
acetylsalicylic acid. 
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FIG. 4. Comparison of the rate of absorption as deter-
mined in vitro and in vivo for (A) chloramphenicol and 
(B) urea. 
leading to a flu)l' which reaches a maximum (tmaxl 
at 4 to 8 hr. Agreement with the rate of absorption 
as determined in vivo is good in these two cases, 
although the lack of in vivo data at early times 
severely limits the comparison. It must be empha-
sized that what is being looked for in this and 
subsequent Figures are similarities in the overall 
rate of absorption pattern, not precise quantitative 
agreement. The quantitative aspects of this work 
will be discussed in the next section of the paper. 
In Figures 3A and B, the rates of absorption of 
caffeine and acetylsalicylic acid are presented. 
These two molecules differ from the preceding two 
in that the maximum flux rate occurs much later, 
at 16 to 24 hr. and the rate of buildup and decay 
are accordingly much smaller. Again, the agree-
ment between the in vitro and in vivo kinetics is 
good, especially the time at which the tmax occurs. 
In Figures 4A and B, the rates of absorption of 
chloramphenicol and urea are presented. Here, the 
absorption pattern observed is quite distinct from 
that displayed by the previous 4 compounds. There 
is an absence of a distinct peak in the flux rate, 
with only a slow buildup to a pseudo steady state. 
Both methods are in substantial agreement as to 
the overall absorption pattern, particularly the 
absence of a prominent tm.,. The much greater 
discrepancy in the absolute magnitude of the flux 
noted in this Figure as compared to the previous 
Figures will be discussed subsequently. 
Comparison of the in vitro rate of absorption 
with that determined in vivo yielded good correla-
tion in 11 of 12 cases. The one exception was 
thiourea. Since this was the only exception it 
seemed important to take a closer look at the 
compound, and new in vivo data were obtained. • 
To assure a more accurate comparison, the new 
data were obtained using the abdomen, rather 
than the forearm, as the site of application. This 
time a different absorption pattern emerged from 
the in vivo data, and good agreement with the in 
vitro data was observed. The difference in the site 
of application may have been the reason for the 
• The author is indebted to Drs. R. J. Feldmann and 
H. L Maibach, Department of Dermatology, University 
of California School of Medicine, San Francisco, for 
obtaining new in vivo absorption data on 6 subjects. 
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discrepancy. although it is also possible that the 
original data were in error, since the individual 
rate values for thiourea given in Table III of 
Feldmann and Maibach [7] do not sum to the 
value given for total absorption in the same table. 
Total Absorption 
In addition to the rate of absorption, the other 
component of the in vivo study [7] to which in vitro 
data may be compared is the total quantity of each 
compound absorbed. Although at first appearance 
this would seem to be a simple task, it is in reality 
a very formidable one. Indeed, there are at least 
two crucial factors that make a precise, quantita-
tive comparison of the present data with the in vivo 
data difficult. These are: ( 1} a difference in the site 
of application, and (2) the absence of desquama-
tion in excised skin. 
The first factor is easily understood. Regional 
differences in the permeability of skin have been 
previously reported [13, 14]. At the present time it 
is impossible to say whether or not this variation in 
permeability is related to anything more than a 
regional variation in barrier thickness. and for this 
reason its effect on the present data cannot be 
precisely estimated. 
The second complicating factor is that of de-
squamation. a process which obviously could not 
be duplicated in the in vitro work. In living man it 
leads to a continuing reduction in the amount of 
material remaining on the skin following a single 
dose, even in the absence of significant permea-
tion. Failure to suitably account for this process in 
in vitro work would lead to an overestimation of 
the true absorption value. However, available data 
do allow for a reasonable accounting of the effect of 
this factor. 
The problem can be reduced to the following 
simple question. What period of time in an in vitro 
absorption experiment is equivalent to 5 days, the 
time period used in vivo? In this work. 2 days have 
been chosen as the equivalent time, based on both 
a knowledge of the turnover time of the stratum 
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corneum and the kinetics of the absorption process 
itself. Several authors [15, 16] have demonstrated 
that the stratum corneum renews itself approxi-
mately once every 2 weeks. Since the normal, 
abdominal stratum corneum is 14 to 16 cell layers 
thick [16 ], it can be concluded that an average of 1 
cell layer per day is shed. It follows then, that after 
1 day any material which has not partitioned into 
the stratum corneum and diffused beyond the first 
cell layer is lost. However, material which had pen-
etrated deeper into the stratum corneum is not 
affected and would eventuallv diffuse into the blood 
(in vivo) or dermal bathi;g solution (in vitro), 
appearing at times greater than 1 day. Thus, the 
equivalent time must be greater than 1 dav. 
Consideration of the kinetics of the abs~rption 
process as just presented suggests that 2 days is a 
reasonable equivalent time. The data of Figures 2 
and 3 demonstrate that the greatest amount of 
absorption takes place in the first 2 days. Thus. 
extending the equivalent time beyond 2 days 
would have only a minor effect on total absorption 
and there is no need to consider subsequent times. 
Although the same argument does not hold for 
compounds displaying a slow rate of absorption, in 
order to have some basis for comparison, an 
equivalent time of 2 days will be adopted as a 
reasonable first approximation. 
The quantitative results of the present study are 
given in the Table. with the values obtained in 
vivo [7] also being given. Due to the presence of a 
few high, outlying values obtained in the in vitro 
work, the median was found to be a better measure 
of central tendency than the mean, and is therefore 
used in the Table. 
Several things are immediately evident from the 
data presented in the Table. Quantitative agree-
ment between the two methods is far from perfect. 
This is particularly true with compounds of low 
permeability, numbers 1 through 3 in the Table, 
where the in vitro nicotinic acid figure differs by an 
order of magnitude from its in vivo counterpart. 
Compounds of high permeability are in much 
TABLE. Total absorption (expressed as percent of applied dose) 
Compound 
1. Hippuric acid 






8. Acetylsalicylic acid 
9. Salicylic acid 




0.2 ± 0.1 [7] 
0.3 ± 0.1 [3] 
0.9 ± 0.2 [3] 
2.0 ± 2.5 [6] 
4.4 ± 2.4 [3] 
6.0 ± 1.9 !4] 
11.1 ±6.2[7] 
21.8 ± 3.1 [3] 
22.8 ± 13.2 [17] 
42.6 ± 16.5 [6] 
47.6 ± 21.0 [12] 
53.1 ± 12.4 [4] 
In Vitro0 
1.2 (0.8, 2.7) [15 [ 
3.3 (0.7 0 8.3) [19 [ 
3.4 (2.4. 5.5) [52] 
2.9 ( 1.0, 5. 7) [12] 
10.9 (7.7, 26) [7] 
11.1 (5.2, 29) [22] 
28.8 (16, 65) [21] 
40.5 (17, 49) [14] 
12.0 (2 3, 23) [10] 
44.9 (29. 53) [18] 
9.0 (5.5, 20) [17] 
27.5 (19, 33) [18] 
• Mean ± standard deviation. Th~ figure in brackets is the number of subjects studied. 
• Median with 95% confidence interval given in parentheses. 
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better agreement, and 6 compounds differ by less 
than a factor of 2. Caffeine and nicotinamide are 
the only members of this group for which the 
agreement is not good. 
Although the absence of exact quantitative 
agreement between the two methods is evident, an 
obvious trend toward positive correlation can be 
noted. This is more clearly demonstrated in Figure 
5, in which the in vitro values have been plotted as 
a function of the in vivo values. A statistical 
examination of the data has also been made using 
Spearman's test for rank order correlation [17 ]. 
The correlation is found to be highly significant, 
p < .01, and the correlation coefficient is .734 (1.000 
perfect correlation). 
DISCUSSION 
This work demonstrates that the study of percu-
taneous absorption in excised human skin does 
indeed give information which is relevant to its 
living counterpart. When equivalent techniques 
are used, the data obtained from in vitro prepara-
tions of skin correlate well with those obtained in 
vivo. Specifically, the data presented here demon-
strate that the in vitro technique is capable of 
differentiating compounds of low permeability 
from those of high permeability, and ranking them 
in an order which closely approximates that seen in 
vivo. Moreover, there is excellent correlation be-
tween the kinetics of the absorption process as 
determined in vitro and in vivo, and therein lies a 
strong argument to support the validity of the in 
vitro method. 
While no systematic attempts appear to have 
been made previously to relate in vitro and in vivo 
absorption data, there does exist in the literature 
some information which demonstrates a positive 
correlation between the two techniques. In most 
cases it is only qualitative in nature. For example, 
the well-known enhancement of penetration that 
occurs in living man following increased hydration 
of the stratum corneum can be demonstrated using 
excised skin [14,18-20]. Likewise, the enhance-
ment of hydrocortisone penetration, as well as 
other materials, by the solvent dimethylsulfoxide 
J 
!•o~ 
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FIG. 5. Log-log plot of the total absorption determined 
in vjtro versus that determined in vivo. 
Vol. 64, No.3 
can be demonstrated by either technique [21,22]. 
Furthermore, there is agreement between the two 
techniques that nicotinic acid is far less permeable 
than its ethyl ester [18,23]. Even with respect to 
steroids there is reasonable agreement between the 
in vitro and in vivo methods in separating those of 
low permeability from those of high permeability 
[1,12,24]. 
In general, whenever a question is asked requir-
ing only a qualitative or directional answer, the in 
vitro technique appears perfectly adequate. In-
deed, the present work substantially extends previ-
ous observations and points out the precision with 
which the in vitro method mirrors the absorption 
process occurring in living man. What is currently 
lacking is information which speaks to the quanti-
tative correlation between in vitro and in vivo 
absorption. Although the data presented here dem-
onstrate an unmistakable trend toward quantita-
tive agreement when considering all the data, they 
do not answer the question conclusively. 
As has already been pointed out, precise quanti-
tative agreement should not have been expected in 
view of important differences which existed be-
tween the two studies (different sites of applica-
tion, and the absence of desquamation in vitro). 
One further factor which needs to be considered is 
the accuracy of the in vivo data, particularly at low 
rates of absorption where the difference between 
the two methods is the greatest. 
Perusal of the in vivo data [7] reveals that 5 
days, the time period during which urine was 
collected, is not an adequate time for all absorbed 
material to be excreted. In only 2 of the 12 cases 
studied in vivo is no radioactivity found in the day 
5 urine. For compounds having a slow rate of 
absorption this may introduce a sizable error in the 
total absorption figures. Indeed, for nicotinic acid, 
the amount found in the day 5 urine is larger than 
the sum of the previous 4 days. Interestingly, 
nicotinic acid is the compound for which the 
greatest difference between the two methods is 
observed. Thus, it seems likely that some of the in 
vivo values for total absorption are significantly 
underestimated, especially those associated with 
compounds having a slow rate of absorption. This 
could easily account for the greater divergence in 
the results of the two methods seen with low 
absorption values. 
The author is indebted to the following for their review 
of this paper: Dr. I. H. Blank, Massachusetts General 
Hospital; Dr. A.M. Kligman, Hospital of the University 
of Pennsylvania; Drs. K. Kraning and G. F. Odland, 
University of Washington School of Medicine; and Dr. J. 
T. Van Bruggen, University of Oregon Medical School. 
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